Search Results

Filter Results

Reset filters

Date

All Dates

Past 7 Days 0

Past 30 Days 0

Past year 3

Custom range

Custom Date Range

Start date: End date:

Topic

All Topics

Public Health 2,053

COVID-19 1,189

States 1,083

Health Industry 777

Global Health Watch 515

Cost and Quality 381

California 339

Pharmaceuticals 278

Health Care Costs 257

Noticias En Español 244

Elections 203

Aging 174

Multimedia 169

Insurance 164

Mental Health 116

Medicaid 105

Race and Health 93

The Health Law 90

Medicare 86

Courts 69

Rural Health 63

Navigating Aging 38

Uninsured 37

Postcards 34

KFF Health News On Air 23

Medi-Cal 12

Asking Never Hurts 7

HealthBent 7

Covered California 4

KFF Health News Impact 3

The New Old Age 0

Content Type

All Content Types

Morning Briefing 1,171

Podcast 8

Story 1,354

Showing 2161-2180 of 2,537 results for "coronavirus"

Sort by Relevance Date

The Navy’s Response To Detecting A Sailor On Board With Coronavirus: Shove Everyone Into One Room Together

March 17, 2020 Morning Briefing

Dozens of officers on the ship were called into tight quarters to be briefed on the situation, even as health experts have emphasized the need for social distancing to stop the spread of the virus.

X
Facebook
LinkedIn
Email
Print

First Human Test Subjects Injected With Experimental Coronavirus Vaccine As Trial Kicks Off

March 17, 2020 Morning Briefing

On the first day of the trial, four healthy volunteers were given the test vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases and Moderna Inc. Meanwhile, other Pfizer is also working to co-develop a vaccine with a German company. Such rapid development is unprecedented, but experts warn that even if one works a vaccine will still not be broadly available for 12-18 months.

X
Facebook
LinkedIn
Email
Print

Italy Closes Most Restaurants, Shops Except For Groceries In An Effort To Halt Devastating Toll Of Coronavirus

March 12, 2020 Morning Briefing

Coronavirus infections climbed by more than 2,000 on Wednesday to surpass the 10,000 mark, with an additional 170 deaths in one day. Italy has been particularly hard hit by the virus, with the outbreak overwhelming its hospital system to the point that doctors are having to decide who to treat and who to let die. Experts have predicted that currently the United States is on the same trajectory as the country in terms of number of expected cases.

X
Facebook
LinkedIn
Email
Print

Longer Looks: Public Housing, Small Pox Experts, Climate Change In The Time Of Coronavirus, And More

March 27, 2020 Morning Briefing

Each week, KHN finds interesting reads from around the Web.

X
Facebook
LinkedIn
Email
Print

Science Vs. Myths: New Study Outlines How Long Coronavirus Lives On Various Surfaces, In The Air

March 18, 2020 Morning Briefing

Published in the New England Journal of Medicine, the study says coronavirus can live for three days on some surfaces. It survives longest on plastic and steel. Other research news is on how long social distancing might be necessary, how long the pandemic can last and the importance of taking walks.

X
Facebook
LinkedIn
Email
Print

CDC Was Viewed As World’s Premier Health Agency. How Did It Stumble So Badly?

June 3, 2020 Morning Briefing

“They let us down,” said Dr. Stephane Otmezguine, an anesthesiologist who treated coronavirus patients in Fort Lauderdale, Florida. The New York Times takes a deep dive into the missteps, outdated technology, bureaucracy and politics that all played a role in the highly venerated agency’s lackluster response efforts.

X
Facebook
LinkedIn
Email
Print

Gilead Rescinds Orphan Drug Status Request For Potential Coronavirus Treatment Amid Exploitation Outcry

March 26, 2020 Morning Briefing

The drugmaker had applied for the status for its experimental drug remdesivir–and was it granted by the FDA–because the number of COVID-19 cases in the U.S. is still under 200,000. The designation would have granted Gilead lucrative perks, including the ability to keep cheaper versions off the market for years. “Gilead must have been feeling the heat,”James Love, director of Knowledge Ecology International told NPR. “I think it’s embarrassing to take something that’s potentially the most widespread disease in the history of the pharmaceutical industry and claim it’s a rare disease.”

X
Facebook
LinkedIn
Email
Print

Blood Test To Identify Who Is Immune To Coronavirus Could Be Game Changer In War Against Outbreak

March 26, 2020 Morning Briefing

Not only could those people be the first wave back into restarting normal life in the country, antibodies in their blood could help other patients with the illness.

X
Facebook
LinkedIn
Email
Print

Gov. Cuomo’s Order To House COVID Patients In Nursing Homes Scrutinized

July 13, 2020 Morning Briefing

Critics have called for investigations to see if the Cuomo administration’s directive forcing nursing homes to accept coronavirus patients from hospitals created a dangerous environment that allowed the virus to quickly spread in New York. But state officials are fighting back. Meanwhile, visits to residents in nursing homes and other long-term care facilities in parts of the country are slowly resuming and other nursing home news.

X
Facebook
LinkedIn
Email
Print

Health Experts, Leaders Acknowledge Black Trauma Even As They Worry Protests Will Worsen Pandemic

June 2, 2020 Morning Briefing

Thousands are taking to the streets to protest police brutality, especially against black Americans. But health experts and state leaders are concerned there’s a high risk that with so many people in close proximity–even though they’re outside–the protests provide fertile ground for the coronavirus to spread further.

X
Facebook
LinkedIn
Email
Print

17-Year-Old’s Death Linked To Coronavirus, Emphasizing That The Young Aren’t Immune To The Outbreak

March 25, 2020 Morning Briefing

While the case is complex in terms of how COVID-19 played a role in the death, California Gov. Gavin Newsom and state health officials say it highlights the risk to young people, who have experienced far lower mortality rates than the older generations.

X
Facebook
LinkedIn
Email
Print

Gilead’s Promising Coronavirus Treatment Granted Orphan Drug Status That Provides Lucrative Incentives For Company

March 25, 2020 Morning Briefing

Gilead could keep lower-priced generic versions of the medicine off the market for several years if remdesivir is approved for use. Gilead was able to secure the status because as of now there are fewer than 200,000 cases in the U.S.

X
Facebook
LinkedIn
Email
Print

Senate Overwhelmingly Passes House’s Coronavirus Bill, Immediately Switches Attention To ‘Phase 3’ Stimulus Package

March 19, 2020 Morning Briefing

President Donald Trump signed the legislation–which among other things mandates free coronavirus testing–after the Senate sent it to his desk. There were worries that the upper chamber wouldn’t move quickly on the bill, but lawmakers are already gearing up for the next round of stimulus negotiations. However, with so much money involved some wonder how a fractured Congress will pass a bipartisan package even during a crisis.

X
Facebook
LinkedIn
Email
Print

China Shut Itself Down To Contain Coronavirus Outbreak. Now Business Leaders Are Saying Enough Is Enough.

February 21, 2020 Morning Briefing

“Strike a balance that is conducive to protecting lives,” urged James Liang, the executive chairman of Trip.com, China’s dominant online travel agency. Meanwhile, public health experts are losing faith in the accuracy of China’s coronavirus count as the method continues to change. In other news from China: the overstretched medical system, the coronavirus in prison, re-hospitalized patients, the politics of an outbreak, and more.

X
Facebook
LinkedIn
Email
Print

‘You Can’t Afford To Make Mistakes’: Will Pence Emerge From Coronavirus A Hero Or A Scapegoat?

March 3, 2020 Morning Briefing

No one is denying the pressure that Vice President Mike Pence faces after President Donald Trump put him in charge of the country’s coronavirus response. So far, Pence has borrowed a page from his gubernatorial playbook by attempting to control government messaging as it relates to coronavirus, and that lack of transparency is drawing criticism. But the vice president is expected to ramp up communications staffing in the coming days. Meanwhile, top health officials in the Trump administration are all adjusting to living under the microscope.

X
Facebook
LinkedIn
Email
Print

Coronavirus Mostly Spreads Via Tight Social Clusters Which Scientists See As A Weakness To Be Exploited

March 23, 2020 Morning Briefing

Scientists say the way the illness is mostly spreading is through close contact between friends, family members and colleagues. That means if officials can get ahead of the outbreak, they can test and isolate and then perhaps hold off the worst of the spread. Meanwhile, despite a rising sense of urgency around the globe and governments’ directives to practice social distancing, there are some who still won’t listen.

X
Facebook
LinkedIn
Email
Print

Facing Widespread Criticism, Trump Administration To Launch ‘Radical Expansion’ Of Coronavirus Testing

March 2, 2020 Morning Briefing

The FDA gives laboratories and hospitals across the country the go-ahead to conduct tests that were previously limited to those analyzed by the CDC. Early delays and restrictions on testing is the target of vocal criticism about the government’s response to the COVID-19 outbreak. Meanwhile, HHS launches an investigation into flawed tests that derailed early detection.

X
Facebook
LinkedIn
Email
Print

WHO Sees ‘Green Shoots Of Hope’ In Steroid Study, But Says Drug Should Be Saved For Most Severe Cases

June 18, 2020 Morning Briefing

A cheap, common steroid significantly cuts the mortality rates in severe COVID-19 cases. While many public health leaders celebrated the news, some are more cautious. Meanwhile, WHO stops its trial of the controversial anti-malarial drug that has dangerous side effects and has yet to show any benefit for coronavirus patients.

X
Facebook
LinkedIn
Email
Print

Cruise Ship Quarantined After 10 Passengers Test Positive For Coronavirus

February 5, 2020 Morning Briefing

The ship, carrying about 3,500 people, is quarantined off the coast of Japan. Princess Cruises said a guest who later tested positive for coronavirus sailed from Yokohama on Jan. 20 and disembarked at Hong Kong on Jan. 25. The confirmation set off a round of testing for 273 people, including a U.S. guest who then tested positive for the illness.

X
Facebook
LinkedIn
Email
Print

Novartis To Conduct Malaria Drug Study Even As Early Data Hint That It Doesn’t Fully Protect Against Coronavirus

April 20, 2020 Morning Briefing

The study will be a randomized, double-blind placebo-controlled study, unlike the research being done on the fly treating severely ill patients. The decision was announced as emerging data show people who are taking hydroxychloroquine are still becoming infected with the virus. Meanwhile, President Donald Trump’s tendency to tout possible cures in the early stages of testing is upending pharma’s traditional PR machine. And Reuters offers an overview of where we stand on drug and vaccines.

X
Facebook
LinkedIn
Email
Print

More From KFF Health News

StéAira Ballard holds a framed photo of her mother, Tamala Smith.

Cosmetic Surgery Investigation Prompts Warnings for Patients, and a Push for Tighter Safety Standards

The exterior of a medical clinic with a sign reading "Celebrating 25 years"

Primary Care Is in Trouble. So Doctors Band Together To Boost Their Market Power.

Two photos shown side by side: On the left, a young boy has a bloody gauze in his mouth. On the right, a hand holds an extracted tooth.

More Kids Are in ERs for Tooth Pain. Trump Cuts and RFK Jr.’s Anti-Fluoride Fight Aren’t Helping.

A senior man looks at a credit card while on his phone

Banks Are Becoming Bulwarks Against Scams for Vulnerable Seniors